South Korea Biomarkers Market Size, Share, and COVID-19 Impact Analysis, By Type (Efficacy Biomarkers, Safety Biomarkers, and Validation Biomarkers), By Product (Consumables, Services, and Software), and South Korea Biomarkers Market Insights, Industry Trend, Forecasts to 2035

South Korea Biomarkers Market Insights Forecasts to 2035

• The South Korea Biomarkers Market Size was Estimated at USD 1,603.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 13.95% from 2025 to 2035
• The South Korea Biomarkers Market Size is Expected to Reach USD 6,744.3 Million by 2035

According to a research report published by Spherical Insights and Consulting, The South Korea Biomarkers Market Size is anticipated to reach USD 6,744.3 Million by 2035, growing at a CAGR of 13.95% from 2025 to 2035. Within the major factors propelling the market are the increasing integration of omics technologies, including proteomics, metabolomics, and genomics; the growing integration of AI and ML; and the growing investments in R&D.

Market Overview

The market for biomarkers in South Korea includes a wide variety of biological and medical indicators that are used to identify, diagnose, track, and forecast the course of different illnesses. Biomarkers are quantifiable compounds or traits found in the body that reveal information about pathogenic processes, normal biological processes, or pharmacologic reactions to treatment. Additionally, the current one of the key drivers driving the market expansion in South Korea is the growing integration of omics technologies, including proteomics, metabolomics, and genomics. Developments in these areas are making it easier to identify a wide range of biomolecules that can act as accurate and targeted indicators for different illnesses. The nation's efforts to implement personalized medicine are being aided by the ability to examine a person's molecular profile, which enables more precise and focused diagnosis. In addition, the market is expanding due to the increased incidence of chronic illnesses like cancer, heart disease, and neurological conditions. Biomarkers are essential for the early identification and tracking of these disorders, which helps with prompt treatment and better patient outcomes.

Report Coverage

This research report categorizes the market for the South Korea biomarkers market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea biomarkers market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea biomarkers market.

Driving Factors

A promising market outlook is being provided by the increasing incorporation of machine learning (ML) and artificial intelligence (AI) into biomarker analysis and discovery. Aside from this, precision medicine is concerned with adjusting medical procedures to each patient's unique characteristics, taking into account their genetic composition, way of life, and surroundings. Because they make it possible to examine patients who are likely to respond favorably to particular treatments, biomarkers are essential to this strategy. Furthermore, the market is expanding due to the growing need for non-invasive biomarkers, which is being driven by the desire to improve patient compliance, lower healthcare costs, and improve the overall diagnostic experience.

Restraining Factors

Genetic testing and companion diagnostics are frequently needed for the creation and use of biomarkers, and these procedures are more costly than conventional ones. The extensive use of biomarker-based techniques is restricted by this financial barrier, especially in environments with limited resources.

Market Segmentation

The South Korea Biomarkers Market share is classified into type and product.

• The safety biomarkers segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea biomarkers market is segmented by type into efficacy biomarkers, safety biomarkers, and validation biomarkers. Among these, the safety biomarkers segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. These biomarkers have a strong market presence because they are frequently used in clinical trials and drug development to evaluate possible side effects.

• The consumables segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea biomarkers market is segmented by product into consumables, services, and software. Among these, the consumables segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Driven by the increased need for detection instruments, assay kits, and reagents for biomarker research and diagnostics

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea biomarkers market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Celltrion Inc.
• Samsung Biologics
• CHA Biotech
• Boditech Med Inc
• Celemics Inc.
• Others

Recent Developments:

• In June 2025, Cercare Medical, a leader in advanced neuroimaging software, announced that it received additional regulatory clearance in South Korea for its Cercare Medical Neurosuite with Capillary Function, including its advanced perfusion imaging technology.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Biomarkers Market based on the below-mentioned segments:

South Korea Biomarkers Market, By Type

• Efficacy Biomarkers
• Safety Biomarkers
• Validation Biomarkers

South Korea Biomarkers Market, By Product

• Consumables
• Services
• Software